Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinheng Baide Biotechnology, a subsidiary of Bio-Bridge Science, Inc., is a specialized manufacturer of bovine serum products based in Hohhot, Inner Mongolia. The company focuses on the production of high-quality fetal bovine serum (FBS) and newborn calf serum, which are essential raw materials for the development and manufacturing of vaccines and cell-based therapies. Acquired by Bio-Bridge Science in 2010, Xinheng Baide serves as a key supplier to the biopharmaceutical industry in China, leveraging its location in a major cattle-rearing region to ensure a stable supply of raw materials. Its products are used extensively in research and commercial bioprocessing applications, supporting the parent company's broader mission in vaccine development. The company maintains a presence in both Beijing and Inner Mongolia to coordinate its research and manufacturing operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xinheng Baide Biotechnology.